Trials / Completed
CompletedNCT06773013
Safety and Effectiveness of Sonu for Pediatric Nasal Congestion
Safety and Effectiveness of Sonu Acoustic Resonance Therapy for the Treatment of Pediatric Patients With Moderate to Severe Nasal Congestion.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Third Wave Therapeutics · Industry
- Sex
- All
- Age
- 12 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acoustic Resonance (Sound) Therapy | Sonu consists of an acoustic Vibrational Headband worn circumferentially at the level of the forehead; and a Smartphone App, paired to the Headband. The App determines acoustic resonant frequencies of the subject's nasal cavity (using the facial image) and delivers treatment through bone conduction transducers in the headband |
Timeline
- Start date
- 2025-01-09
- Primary completion
- 2025-03-16
- Completion
- 2025-03-30
- First posted
- 2025-01-14
- Last updated
- 2025-09-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06773013. Inclusion in this directory is not an endorsement.